Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vibeke Strand

Showing results (251-260 of 435) with videos related to

Pageof 44
Sort By:
Annals of the Rheumatic Diseases|December 16, 2016
Short-term changes on MRI predict long-term changes on radiography in rheumatoid arthritis: an analysis by an OMERACT Task Force of pooled data from four randomised controlled trialsCharles Peterfy, Vibeke Strand, Lu Tian, et al.
Rheumatology (Oxford, England)|May 19, 2012
Sustained efficacy of certolizumab pegol added to methotrexate in the treatment of rheumatoid arthritis: 2-year results from the RAPID 1 trialEdward C Keystone, Bernard Combe, Josef Smolen, et al.
Annals of the Rheumatic Diseases|December 21, 2012
The role of biosimilars in the treatment of rheumatic diseasesThomas Dörner, Vibeke Strand, Gilberto Castañeda-Hernández, et al.
Seminars in Arthritis and Rheumatism|June 5, 2013
Proceedings of the 2013 Rheumatology Winter Clinical SymposiaArthur Kavanaugh, Roy Fleischmann, Martin Jan Bergman, et al.
The Journal of Rheumatology|July 15, 2003
Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteriaThao Pham, Désirée Van Der Heijde, Marissa Lassere, et al.
Rheumatology and Therapy|May 16, 2018
Long-Term Radiographic and Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Treated with Tofacitinib: ORAL Start and ORAL Scan Post-hoc AnalysesVibeke Strand, Arthur Kavanaugh, Alan J Kivitz, et al.
Modern Rheumatology|November 9, 2020
Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: a sub-analysis of the Phase 3 SELECT-EARLY studyTsutomu Takeuchi, Maureen Rischmueller, Ricardo Blanco, et al.
Arthritis Care & Research|March 26, 2024
Improvements in Patient-Reported Outcomes After Treatment With Deucravacitinib in Patients With Psoriatic Arthritis: Results From a Randomized Phase 2 TrialVibeke Strand, Laure Gossec, Laura C Coates, et al.
RMD Open|March 12, 2016
Systematic literature review of domains assessed in psoriatic arthritis to inform the update of the psoriatic arthritis core domain setUmut Kalyoncu, Alexis Ogdie, Willemina Campbell, et al.
The Journal of Rheumatology|July 5, 2011
Development of a disease severity and responder index for psoriatic arthritis (PsA)--report of the OMERACT 10 PsA special interest groupLaura C Coates, Aizad Mumtaz, Philip S Helliwell, et al.
Pageof 44

Showing results (251-260 of 435) with videos related to

Sort By:
Pageof 44
Annals of the Rheumatic Diseases|December 16, 2016
Short-term changes on MRI predict long-term changes on radiography in rheumatoid arthritis: an analysis by an OMERACT Task Force of pooled data from four randomised controlled trialsCharles Peterfy, Vibeke Strand, Lu Tian, et al.
Rheumatology (Oxford, England)|May 19, 2012
Sustained efficacy of certolizumab pegol added to methotrexate in the treatment of rheumatoid arthritis: 2-year results from the RAPID 1 trialEdward C Keystone, Bernard Combe, Josef Smolen, et al.
Annals of the Rheumatic Diseases|December 21, 2012
The role of biosimilars in the treatment of rheumatic diseasesThomas Dörner, Vibeke Strand, Gilberto Castañeda-Hernández, et al.
Seminars in Arthritis and Rheumatism|June 5, 2013
Proceedings of the 2013 Rheumatology Winter Clinical SymposiaArthur Kavanaugh, Roy Fleischmann, Martin Jan Bergman, et al.
The Journal of Rheumatology|July 15, 2003
Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteriaThao Pham, Désirée Van Der Heijde, Marissa Lassere, et al.
Rheumatology and Therapy|May 16, 2018
Long-Term Radiographic and Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Treated with Tofacitinib: ORAL Start and ORAL Scan Post-hoc AnalysesVibeke Strand, Arthur Kavanaugh, Alan J Kivitz, et al.
Modern Rheumatology|November 9, 2020
Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: a sub-analysis of the Phase 3 SELECT-EARLY studyTsutomu Takeuchi, Maureen Rischmueller, Ricardo Blanco, et al.
Arthritis Care & Research|March 26, 2024
Improvements in Patient-Reported Outcomes After Treatment With Deucravacitinib in Patients With Psoriatic Arthritis: Results From a Randomized Phase 2 TrialVibeke Strand, Laure Gossec, Laura C Coates, et al.
RMD Open|March 12, 2016
Systematic literature review of domains assessed in psoriatic arthritis to inform the update of the psoriatic arthritis core domain setUmut Kalyoncu, Alexis Ogdie, Willemina Campbell, et al.
The Journal of Rheumatology|July 5, 2011
Development of a disease severity and responder index for psoriatic arthritis (PsA)--report of the OMERACT 10 PsA special interest groupLaura C Coates, Aizad Mumtaz, Philip S Helliwell, et al.
Pageof 44